Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

421 ARTÍCULOS , VIENDO DEL 166 AL 180

Cognitive performance and neuropsychiatric symptoms in early, untreated Parkinson's disease

Weintraub D, Simuni T, Caspell-Garcia C, Coffey C, Lasch S, Siderowf A, Aarsland D, Barone P, Burn D, Chahine LM, Eberling J, Espay AJ, Foster ED, Leverenz JB, Litvan I, Richard I, Troyer MD, Hawkins KA; Parkinson's Progression Markers Initiative.

Mov Disord. 2015 Jun;30(7):919-27. doi: 10.1002/mds.26170. Epub 2015 Mar 4.

L-Dopa and Brain Serotonin System Dysfunction

Stansley BJ, Yamamoto BK.

Toxics. 2015 Mar 5;3(1):75-88. doi: 10.3390/toxics3010075.

Pharmacological stimulation of metabotropic glutamate receptor type 4 in a rat model of Parkinson's disease and L-DOPA-induced dyskinesia: Comparison between a positive allosteric modulator and an orthosteric agonist

Iderberg H, Maslava N, Thompson AD, Bubser M, Niswender CM, Hopkins CR, Lindsley CW, Conn PJ, Jones CK, Cenci MA.

Neuropharmacology. 2015 Aug;95:121-9. doi: 10.1016/j.neuropharm.2015.02.023. Epub 2015 Mar 4.

Pharmacogenetics of antipsychotic-induced movement disorders as a resource for better understanding Parkinson's disease modifier genes

Greenbaum L, Lerer B.

Front Neurol. 2015 Feb 20;6:27. doi: 10.3389/fneur.2015.00027. eCollection 2015.

Zooming in on the small: the plasticity of striatal dendritic spines in L-DOPA-induced dyskinesia

Fieblinger T, Cenci MA.

Mov Disord. 2015 Apr;30(4):484-93. doi: 10.1002/mds.26139. Epub 2015 Mar 11.

Selective dysfunction of basal ganglia subterritories: From movement to behavioral disorders

Tremblay L, Worbe Y, Thobois S, Sgambato-Faure V, Féger J.

Mov Disord. 2015 Aug;30(9):1155-70. doi: 10.1002/mds.26199. Epub 2015 Mar 15.

Nonmotor symptoms in subjects without evidence of dopaminergic deficits

Sprenger FS, Seppi K, Djamshidian A, Reiter E, Nocker M, Mair K, Göbel G, Poewe W.

Mov Disord. 2015 Jun;30(7):976-81. doi: 10.1002/mds.26204. Epub 2015 Mar 15.

Skin biopsy and I-123 MIBG scintigraphy findings in idiopathic Parkinson's disease and parkinsonism: a comparative study

Giannoccaro MP, Donadio V, Incensi A, Pizza F, Cason E, Di Stasi V, Martinelli P, Scaglione C, Capellari S, Treglia G, Liguori R.

Mov Disord. 2015 Jun;30(7):986-9. doi: 10.1002/mds.26189. Epub 2015 Mar 17.

Clinical validity of the Mattis Dementia Rating Scale in differentiating mild cognitive impairment in Parkinson's disease and normative data

Bezdicek O, Michalec J, Nikolai T, Havránková P, Roth J, Jech R, Růžička E.

Dement Geriatr Cogn Disord. 2015;39(5-6):303-11. doi: 10.1159/000375365. Epub 2015 Mar 18.

Palliative care for Parkinson's disease: has the time come?

Miyasaki JM, Kluger B.

Curr Neurol Neurosci Rep. 2015 May;15(5):26. doi: 10.1007/s11910-015-0542-4.

Saskatchewan movement disorders program

Rajput AH, Rajput A.

Can J Neurol Sci. 2015 Mar;42(2):74-87. doi: 10.1017/cjn.2015.13.

Motion Sensors to Assess and Monitor Medical and Surgical Management of Parkinson Disease

Lieber B, Taylor BE, Appelboom G, McKhann G, Connolly ES Jr.

World Neurosurg. 2015 Aug;84(2):561-6. doi: 10.1016/j.wneu.2015.03.024. Epub 2015 Mar 28.

Impulse control disorder manifesting as hidden sexual self-injury

Brady S, Duffey P.

Pract Neurol. 2015 Jun;15(3):226. doi: 10.1136/practneurol-2014-001038. Epub 2015 Mar 31.

Glycogen synthase kinase-3 beta (GSK-3β) signaling: Implications for Parkinson's disease

Golpich M, Amini E, Hemmati F, Ibrahim NM, Rahmani B, Mohamed Z, Raymond AA, Dargahi L, Ghasemi R, Ahmadiani A.

Pharmacol Res. 2015 Jul;97:16-26. doi: 10.1016/j.phrs.2015.03.010. Epub 2015 Mar 28.

Tango for treatment of motor and non-motor manifestations in Parkinson's disease: a randomized control study

Rios Romenets S, Anang J, Fereshtehnejad SM, Pelletier A, Postuma R.

Complement Ther Med. 2015 Apr;23(2):175-84. doi: 10.1016/j.ctim.2015.01.015. Epub 2015 Feb 9.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias